PLXS

Analyst Note: PLXS (Plexus Corp.)

Date: 2026-06-13 Event Date: 2026-06-13

1. Structural Readiness

• State: Actionable (Forming Coil)
• Conservative Entry: Not yet triggered (requires a close above the breakout level).
• Aggressive/Pre-Breakout Entry: Not applicable for a confirmed setup; currently observing the forming structure.
• Breakout Level: Not yet established (requires price to clear the coil resistance).
• Current Price: $299.97.
• Extension: Not applicable (price has not yet extended beyond the breakout level).
• ATR Context: Current ATR is 3.7% (productive). This sits within the historical "sweet spot" (4–6% is high, but 3.7% indicates productive volatility without the extreme risk of >8% or the weakness of <2.5%).

2. Thesis Layer

• Primary Secular Thesis: Defense Modernization (C4ISR / Sensors / EW).
• Role & Directness: Plexus is a direct beneficiary through its Aerospace/Defense sector, which reported a 23.0% year-over-year sales increase in the most recent quarter. The company's role involves providing advanced electronic manufacturing solutions for mission-critical products, including C4ISR and sensor systems. The evidence indicates "broad-based opportunities" and "new customer" engagement in this sector, suggesting direct exposure to the modernization cycle.
• Additional Secular Tailwinds:
• AI Infrastructure (Semicap Equipment & Materials): While classified as "tier tertiary" with "low confidence" in the secular list, the company explicitly reports "continued share gains in semiconductor capital equipment" and "new engagement in data center power solutions." This provides a secondary, albeit less dominant, structural tailwind.
• Reshoring & Industrial Automation: The company serves the Industrial sector with "double-digit revenue growth" expectations, driven by automation systems and manufacturing efficiency.
• Conviction Weighting: The name is riding a multi-wave structural environment. The Defense thesis is the primary driver of the recent 23% sector growth, while the Industrial and Semicap sectors provide diversification and growth stability. The convergence of these themes suggests a robust, non-cyclical demand profile for the company's manufacturing capabilities.

3. The Business

Plexus Corp. operates as a global provider of advanced electronic manufacturing solutions, specializing in design, development, supply chain management, and core manufacturing for the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors.

• Business Model: The company generates revenue by serving market-leading and disruptive global companies across its three primary sectors. It operates 27 facilities globally with a team of over 20,000 members.
• Key Performance Metrics (as of 2026-06-13):
• Revenue Growth: For the six months ended April 4, 2026, net sales increased 14.2% year-over-year, driven by production ramps and market share gains.
• Sector Performance:
• Healthcare/Life Sciences: Net sales increased 15.1%, driven by $62.9 million in production ramps for new products.
• Aerospace/Defense: Net sales increased 23.0%, driven by $26.9 million in production ramps for existing customers, $9.8 million for new customers, and overall end-market demand.
• Profitability: Gross margin was 10.2% (up 20 bps), and operating margin was 5.3% (up 30 bps) for the quarter ended April 4, 2026.
• Pipeline: The funnel of qualified manufacturing opportunities expanded 11% sequentially to $4 billion as of Q2 FY2026.
• New Wins: The team generated a record $355 million in new manufacturing program wins in the recent period.
• Management Expectations: Management expects to deliver mid-teens or greater fiscal 2026 revenue growth and a 6% or greater non-GAAP operating margin for the full fiscal year. They also forecast fiscal 2026 free cash flow of $50 million to $75 million.

4. Archetype and Conviction

• Archetype: Quality Compounder.
• Fit: The company aligns with the "Quality Compounder" archetype due to its consistent execution on revenue growth (14.2% H1 growth), expanding margins (gross and operating), and a robust pipeline ($4B). Management's long-term goal of 9-12% compounded annual revenue growth and 15% ROIC reinforces this classification.
• Valuation Context: The financial spine indicates a forward consensus EPS of $8.20 for FY1 and $9.48 for FY2.
• Conviction Stack:
• Thesis Strength: High. The company is a direct beneficiary of Defense Modernization and AI Infrastructure, with clear evidence of share gains and new customer wins.
• Evidence Quality: Strong. Multiple primary sources (earnings transcripts, SEC filings) confirm growth, margin expansion, and a healthy pipeline.
• Structural Quality: High. The company operates in a highly competitive market but maintains a diversified customer base (no single customer >10% of sales) and a broad geographic footprint.
• Rerating Potential: Significant. If the company delivers on its mid-teens growth and 6%+ margin targets, the current valuation could re-rate higher, especially given the secular tailwinds.

5. Invalidations, Strengths, and Gaps

• Strengthening: A confirmed breakout above the coil resistance level, accompanied by continued sequential expansion of the $4B pipeline or further margin expansion beyond the 6% target.
• Gaps in Evidence:
• Breakout Level: The specific price level required to confirm the breakout is not defined.
• Customer Concentration Details: While it is noted that no customer accounts for >10% of sales, the specific concentration of the top 10 customers (49.1%) is not broken down by sector, which could obscure sector-specific risks.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: medium Key evidence: Record $355 million in new program wins; 23.0% growth in Aerospace/Defense sector; $4 billion expanded pipeline; management guidance for mid-teens revenue growth and 6%+ operating margin. Key risks: Failure to execute on margin targets (6% non-GAAP); potential slowdown in defense spending or industrial automation demand; customer concentration in top 10 accounts (49.1% of sales). Expected path: Management expects continued revenue growth from program ramps and market share gains; if the breakout fires, the stock may re-rate based on the delivery of mid-teens growth and margin expansion. Expected horizon: 6 to 12 months for the thesis to play out as new programs ramp and fiscal 2026 results are realized.